As further more evidenced by this settlement, the DOJ and SEC proceed to signal the pitfalls associated with unwell-outlined swimming pools of reimbursable distributor expenditures (e.g. “marketing and advertising” or “administration” fees), the usage of absolutely free samples, rebates, and various cost concessions. The Alcon and Novartis